Patent Assignment
Reel/Frame 026787/0289
Confirmatory License
Recorded: 2011-08-22
Pages: 2
Assignor
ALNYLAM PHARMACEUTICALS
Executed: 2011-08-12
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property
(1)
Targeting Lipids
Application:
12/328,669 →
Publication:
US 2009/0247608
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 3, 2009
From: MANOHARAN, MUTHIAH; RAJEEV, KALLANTHOTTATHIL G.; NARAYANANNAIR, JAYAPRAKASH K.; JAYARAMAN, MUTHUSAMY
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 022772/0435 →
Confirmatory License
Jan 20, 2011
From: ALNYLAM PHARMACEUTICALS
To: UNITED STATES GOVERNMENT; DEFENSE THREAT REDUCTION AGENCY
Reel/Frame 025664/0560 →
Assignment of Assignor's Interest
Sep 10, 2013
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 031177/0516 →
Merger and Change of Name
Jul 27, 2018
From: PROTIVA BIOTHERAPEUTICS INC.; ARBUTUS BIOPHARMA CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 046640/0764 →